Authors Posts by Head Editor

Head Editor

5369 POSTS 18 COMMENTS

0 976


ADVANTIS CORPORATION (ADVT ) Connects At Industry Outreach Event

ADVANTIS CORPORATION ( OTC PINK : ADVT ) CEO, Christopher Swartz, attended the Coastal Pacific political action committee’s Southern California Outreach Dinner last Tuesday night. The event was a fundraiser to support cannabis legalization. Swartz was an invited guest of Speedweed CEO, AJ Gentile.


Click Here Now To Read (ADVT) Release


Hemp, Inc. (HEMP) Powers Up Milling Operation for Industrial Hemp Production

Hemp, Inc. ( OTC PINK : HEMP ) is pleased to announce today that the milling portion of its industrial hemp decorticator is now online for beta testing and debugging. The disconnect switch, which connects the power to feed the 200-horse power motor on the grinder, was the final piece executives were awaiting to power up the mill. With the disconnect switch now installed, the team has powered up its hemp mill to beta test and debug the equipment. So far, the team has encountered some small software communication issues, but according to David Schmitt, COO of Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, those types of issues are the norm for the milling machinery and were expected.


Click Here Now To Read (HEMP) Release


 


INDUSTRY UPDATE: Biotech and Marijuana

Although researchers are beginning to learn about the medical benefits associated with cannabis, they have not even scratched the surface. The cannabis industry is the fastest growing industry in the world. After spending several years researching cannabis and developing products, companies are just beginning to realize the fruits of their efforts.


Click Here Now To Read Full Article


 

0 829

Advantis Corp. Connects At Industry Outreach Event

ADVANTIS CORPORATION ( OTC PINK : ADVT ) CEO, Christopher Swartz, attended the Coastal Pacific political action committee’s Southern California Outreach Dinner last Tuesday night. The event was a fundraiser to support cannabis legalization. Swartz was an invited guest of Speedweed CEO, AJ Gentile.

Advantis partnered with Speedweed several months ago, and the relationship has been growing ever since. “I am thankful that AJ (Gentile) appreciates the quality, value, reliability, and service we strive to provide with every product,” Swartz explained. “This partnership has opened several doors for us; this event invitation was just another example of how AJ has significantly impacted our expanding footprint, and I am eternally grateful.

“I networked with elected officials, law enforcement, and leaders in the California cannabis industry, a few of whom are very significant on a global scale and have a paramount emphasis on the legal, compliance, distribution, marketing, and funding of organizations in the cannabis industry, as well as being focused on the development and sustainability of the global cannabis market. “Between these companies and the lawmakers I spoke with, I think the guidance we are getting, and the tremendous corporate connections, will help expand our business and hopefully position Advantis nicely for a coveted distribution license in California,” Swartz revealed.

Swartz elaborated on how he was able to connect with other attendees at the prestigious event. “I met several new people and some old ones,” Swartz said. “A few of the people we connected with at the Cannabis Expo in March were there, and it was good to reignite some stalled conversations.” Swartz added that the networking opportunity at the $1,000 per plate dinner was unmatched. “I think we will be able to solidify some of ideas we left on the table back then. We have been working on a solution to connect property owners with licensed cultivators, for example, and pieces of this puzzle are coming together.” Swartz stopped short of describing the real estate play, but added that there are several new products that Advantis will introduce as progress is being made on “those” fronts. “We are getting our guidance from the highest levels of government and most respected industry leaders,” Swartz elaborated. “We are aggressively working toward obtaining a state distribution license, which we feel will be a game changer.” The California legislature is currently working on codifying Proposition 64 into law after its passage in November. Prop. 64 legalized recreational use of marijuana in the state of California. “We are at the leading edge of this industry and our footprint continues to expand,” Swartz concluded.

Pictures of the event can be found on the Advantis Facebook site.

Links to Advantis websites can be found at advantiscorp.com, elixicure.com, and amstercan.com

About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes domestic and national partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

0 1498
Marijuana-Stocks-Cannabis-weed-11

Because recreational marijuana has the possibility of popping up soon, the Reno Police Dept. is reminding possible consumers and current residents of the rules when sales begin.

Marijuana, much like alcohol cannot be smoked in any public place including but not limited to; parks, sporting events, casinos, hotels, concerts, festivals and special events. If one chooses to do so anyway, they will be fined $600 for their first offense.

The only place where it is legal to consume marijuana is at a private residence or in the comfort of your own home.

The only people eligible to purchase recreational marijuana are those who are over twenty-one years of age. If a person is eligible, they are only allowed to possess one ounce of marijuana or one-eighth of an ounce of concentrated cannabis.

It is technically legal for homeowners to grow up to six plants per person however the law stipulates that you cannot grow marijuana if you live within twenty-give miles of a dispensary. This makes growing in Reno or Sparks essentially off-limits.

You can legally keep cannabis within your vehicle, but the laws of driving-under-the-influence (DUI) still apply. Law enforcement can pull you over and administer classic field sobriety tests and ask if the suspected DUI-er consents to a blood test.

The Reno Police Department is still working out all of the details with legalizing the plant including the laws of being under the influence in public and more. Deputy Chief Tom Robinson said “That’s a tricky question. I don’t see the Reno Police Department aggressively enforcing people being under the influence. I do see it being reserved for those extreme cases where someone is aggressive o extremely uncooperative.”

Another gray area is if a person carrying a legal amount of marijuana is arrested for an unrelated crime, can the officers take the legal marijuana into their possession?

“Because it’s federally illegal, we’re concerned that we’re violating federal law if we give the individual back their marijuana, so those are issues that are still hanging in the balance.” Robinson stated.

From now on we will see the path that recreational legalization takes on Reno. It is a complicated area of legislation but the police and lawmakers of Reno are working hard to figure out the details.

0 205

Tauriga Sciences, Inc. Fully Repays $40,000 USD Face Value Convertible Debenture for One Time Cash Payment of $59,658.96 USD

The Company’s management and Board of Directors have established a long term corporate goal to be completely free of convertible debt. Significant efforts will be made by the Company moving forward to retire additional tranches of its existing convertible debt.

Tauriga’s Chief Executive Officer, Seth M. Shaw, expressed, “The Company is working diligently to curtail potential future share dilution and is pleased to have repaid this convertible debenture for this one-time cash payment. The Company continues to believe that it is making important progress on a number of strategic initiatives, including the anticipated launch of its Cupuacu Butter lip balm product. My recent personal investments into the Company should underscore my belief in our future prospects and my commitment to both restore and create long term value for our loyal shareholder base.”

ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. ( OTC PINK : TAUG ) is a fully reporting life sciences company engaged in the development, marketing, distribution and potential licensing of a broad array of products and technologies that may help individuals who are affected by muscle tension. The Company has already identified potential products and technologies of interest and is actively working towards the goal of creating an innovative product line to launch the business activities of ColluMauxil Therapeutics LLC. The Company believes that one of its most important strengths is its access to and relationships with potentially substantial distribution systems and networks. The Company intends to capitalize on distribution opportunities and will continually update shareholders on such developments. The Company is also prosecuting (as Plaintiff) its ongoing malpractice lawsuit against its predecessor audit firm, for which it’s seeking monetary damages in excess of $4,500,000 USD.

NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.

DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation: expectations, expects, anticipates, believes, hopes, beliefs, plans and objectives regarding the development, use and marketability of products as well as the attainment of certain corporate goals and milestones (i.e. SEC Periodic Filings, Filing of Proxies, etc.). Such forward-looking statements are based on present circumstances and on Tauriga’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.

0 851

Hemp, Inc. Powers Up Milling Operation for Industrial Hemp Production

To see Hemp, Inc.’s video just posted entitled, “The Largest Hemp Mill in the Western Hemisphere is Now Online – It’s Alive”, click here.

“Since the software communication issues we are experiencing now were expected, software programming, which is part of the debugging process, is solving those issues. We expect to finish beta testing and debugging in about a week or two,” said Schmitt. Now that the hemp mill in Spring Hope, North Carolina is online and being debugged, Schmitt is in Brazil to start marketing and sales efforts in that country. He is scheduled to meet this week with several companies he previously did business with that are interested in Hemp, Inc.’s lost circulation materials (LCMs) and companies interested in using Hemp, Inc.’s fiber in the non-woven industry. Schmitt has also scheduled meetings with companies that he hopes to sell Hemp, Inc.’s CBDs to.

To see Hemp, Inc.’s video just posted entitled, “The Largest Hemp Mill in the Western Hemisphere is Now Online – It’s Alive”, click here.

As previously mentioned, Hemp, Inc. is planting 17 acres of one strain of high-CBD clones between North Carolina and Colorado. Hemp, Inc.’s licensed farming associates in North Carolina have secured over 150 pounds of a different strain of CBD-rich hemp seeds, which are currently being planted in order to be harvested by September/October. This will be one of, or, the largest CBD hemp grows in the United States (approximately 550 acres total). “Our infrastructure is solid. We have our NuAxon Tech CO2 Supercritical extractor from NuAxon BioScience CBD Extractor at our industrial hemp plant in North Carolina and expecting to acquire a second extractor soon so we’ll be prepared to accommodate the industry’s expanding CBD market,” said Bruce Perlowin, CEO of Hemp, Inc. ( OTC PINK : HEMP ).

To see Hemp, Inc.’s video just posted entitled, “The Largest Hemp Mill in the Western Hemisphere is Now Online – It’s Alive”, click here.

“Additionally, we are in negotiations to joint venture with a huge 40,000 square-foot room Extractor, capable of producing 1,000 to 3,000 pounds of CBDs per day based on how many shifts we run, located less than one hour away from our plant in North Carolina,” continued Perlowin.

According to Forbes.com, the CBD market is expected to grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources. That’s a 700% increase from 2016.

The Rocky Mount Telegram, a North Carolina news source, featured Perlowin, Schmitt, and Hemp, Inc. on the front page of yesterday’s Sunday paper, entitled “Spring Hope Firm Bets on Hemp” as Spring Hope’s hemp plant making hemp the next cash crop for local farmers. “Several workers Friday were planting the last five acres of the more than 550 acres of high-CBD clone industrial hemp plants at a farm in Franklin County. Perlowin said the high-CBD clone industrial hemp plants were being planted on farms in both Franklin and Nash counties.” To read the full article in The Rocky Mount Telegram, click here.

The Hemp University’s The Art and Science of CBD Greenhouse Growing held at Louisburg College this weekend was a huge success. A team of experts engaged attendees through the greenhouse and indoor growing process; from cultivation to harvest and from processing to distribution. Dr. Robert Bruck, Dean of Science, Technology, Engineering and Mathematics and Distinguished Professor of Environmental Science at Louisburg College, was the special guest who presented during this symposium. Half of the course took place at Hemp, Inc.’s 70,000 square-foot industrial Hemp Hub, in a 3,000 square-foot cloning room, whereby attendees had the opportunity to experience a more hands-on learning approach. A more detailed description of The Hemp University’s symposium will be issued this week.

0 441
marijuana-stocks-cannabis-update

In 1912, the Better Business Bureau (BBB) was founded to provide consumers with protection and to self-regulate various industries.

105 years later, the BBB has gone back to its original motives and has begun to regulate the marijuana industry, assuring consumers are not getting beaten by fraudulent online scams.

Having received a tip through a service BBB created called Scamtracker, the Bureau stepped up to the plate and began investigating two web-based businesses. Those businesses were Denver Marijuana and Denver Smoke Buds.

The investigation they ran found that the fake companies claimed to be selling a large amount and variety of substances like bath salts (the drug for notoriously making people eat others faces) and “research chemicals”, as well as some marijuana products.

First, they checked out the business addresses, which didn’t compute in any system, as well as their hyperlinks leading to false addresses.

Krista Ferndelli, director of marketing and communications for the BBB of Denver stated in a press release that “One huge red flag for us is when there is no link to register with the Colorado Secretary of State. Both of these places show no owner, no managing staff, and have some sketchy information about where they are based.”

The first of the two, Denver Smoke Buds, claims in some places on its website to be based out of Atlanta, Georgia, while on other pages it claims to be based out of Denver.

“Whenever we called them, they would deliberately hang up. They also list themselves as winners of fake awards on their website.” Ferndelli said.

The BBB speaks to consumers and says that mail-order weed is very illegal on all state and federal levels and one should go through the process legally if they went to obtain marijuana.

“The BBB can always be a good way to check if a business is legitimate,” Ferndelli suggested. “Make sure to listen to other people in the marketplace and try to understand the laws surrounding marijuana.”

0 798
Marijuana-Stocks-Cannabis-DEA

There are so many fronts in the war for marijuana legalization that it’s an arduous task to monitor all of them, yet the job has never been more important. And Last month, the Drug Enforcement Administration stealthy over-stepped its boundaries (again) and advanced its prohibitionist agenda. The mainstream media failed to report this, and it was through Technical 420’s own careful review of recently amended DEA codes that this was uncovered.

In October of 2016, the Cannabis Community was sent in to an uproar when the Department of Justice’s Drug Enforcement Administration tried to make CBD Oil’s illegal by redefining what constituted as marijuana extract under the “Final Rule establishing a new Controlled Substance Code Number (drug code) for marijuana extract”. You can read it here: https://www.deadiversion.usdoj.gov/fed_regs/rules/2016/fr1214.htm

The important part of the code can be found under ‘Final Action’ where it states: “Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.”

Essentially, last October, the DEA tried to categorize any extract from any part of the marijuana plant as a schedule one substance. This excluded extracts from resin or seeds, however, any other extract was a schedule 1 narcotic regardless of THC content.

Private companies, non-profits, and advocacy groups struck back with lawsuits claiming the law was over-reaching. And it seemed that the DEA backed off, and the cannabis community sighed a breath of relief.

However, sometime last month, the DEA quietly and unannounced posted an amendment to the code. The mainstream media, and even most CBD manufacturers, failed to pick it up this new posturing from the DEA. You can read it in full here:

https://www.deadiversion.usdoj.gov/schedules/marijuana/m_extract_7350.html

Under the “Clarification of the New Drug Code (7350) for Marijuana Extract” the definition of marijuana extract changes. While they do make changes to better structure their own legal grounds on the definition of what is marijuana extract, the important part of this updated code is that now anything extracted from marijuana is also included as a schedule one substance.

Just to highlight how absurd this is, consider that you can extract pure omega fatty acids from cannabis resin. No cannabinoids, no THC, just Omega (like 3, 6, & 9) Fatty Acids. The DEA literally just claimed that Omega Fatty Acids are a schedule 1 controlled substance when extracted from cannabis. Enough said.

To be as clear as their new rule is: Anybody selling CBD oil is now undoubtedly and unequivocally selling a schedule 1 substance. Seeds, while still not included in the code, are the only part of the cannabis plant that cannot produce quality CBD oils, just hemp oil.

It now is clear that their goal is to strengthen their positioning in their upcoming court battles over CBD’s scheduling classification. The updated code attempts to redefine CBD to include extracts and attempts to skirt around most of the legal claims of law suits already in the courts dockets. It’s an incredibly unethical and corrupt move.

Not to mention, these codes do not come from elected officials, but rather from bureaucratic actions that do not represent the American people. We will, of course, be keeping an eye on this latest development very closely.

Authored By: Jason Spatafora

0 428
Marijuana-Stocks-Cannabis-nug-14

Up until its legalization, marijuana has been a black-market business relying solely on cash. As the business moves out of the shadows and gets it rightful government oversight, new regulators have been hired to make sure laws are being followed. All of these regulators have no experience given the nature of the industry being brand new.

The result of this can sometimes be a perfect mixture for government corruption.

Many recent cases noted in Colorado and Washington have dealt with the issue of current or former marijuana regulators and their accusal of improper dealings within the industry of legal cannabis. This is shocking given that the two recreational marijuana states have the oldest recreational programs in the country, having weed legalized in defiance of federal law since 2012.

A few cases several years into marijuana’s legalization may not seem like a big deal to many, but all it takes is a few to make a large dent in the confidence behind a medical marijuana industry. This can also bring back the feeling that the industry is criminal and fuel many fears behind its illegitimacy.

One of the cases states that former Colorado marijuana enforcement officer Renee Rayton, is accused of helping pot growers grow plants for use in out-of-state sales.

After being accused, state investigators say that the former inspector quit her job and immediately went to work for the illegal pot ring, yielding an eight thousand dollar per month job.

In Washington, the state agency behind regulating marijuana recently fired an employee who controlled the leasing of land to a prospective pot grower.

The man behind the accusal is named Grant Bulski. Bulski was charged with leasing twenty-five acres of land to a marijuana entrepreneur for close to three-thousand dollars per month. The law forbidding this states that pot regulators cannot have a financial state in the businesses, however Bulski was not charged with any crime.

These may be just a few cases concerning the affects of the recreational marijuana, but all it takes is a few to take the public into believing the market is illegitimate. However, do some research and quickly find that the market has a history of legitimacy and medicinal benefit to all who use.

0 450

Canabo Opens Second Nova Scotia Clinic and Announces Appointment of Garry Stewart as Chief Financial Officer

As previously discussed on June 5 in the Company’s Corporate Update, the clinic reports new patient volumes continue at record levels.

Dr. Neil Smith, Executive Chairman of Canabo Medical Inc. stated, “As explained in our June 5th Corporate Update we reiterate, there was no fundamental reason for the sharp decline in our share price during May. The Company’s operating fundamentals and growth trajectory remain strong.”

Canabo also announces today the appointment of Mr. Garry Stewart as Chief Financial Officer.

Mr. Stewart is a Chartered Professional Accountant who brings over 25 years of professional experience to the role. Prior to joining Canabo, Mr. Stewart served as CFO, Vice President Finance at TAR Investments Ltd., including Datarite Ltd. and Atlantic Business Interiors Ltd.

Mr. Stewart replaces Mr. Rob Randall as Chief Financial Officer. Mr. Randall is leaving Canabo to focus on his other CFO roles but will continue to support and assist Mr. Stewart during the transition. John Philpott, President & CEO of Canabo, commented, “I would like to thank Rob for his service to Canabo. He played a key role in the RTO transaction as well as the growth of the business. We wish him well in his future endeavours.”

About the Company

Canabo wholly owns and operates Cannabinoid Medical Clinics, or CMClinics, Canada’s largest physician led referral-only clinics for medical cannabis. Established in 2014, Canabo now has 22 clinics across Canada, with additional locations planned to open in 2017. Canabo operates referral-only medical clinics dedicated to evaluating the suitability of prescribing, and monitoring cannabinoid treatments for patients suffering from chronic pain and disabling illnesses. Clinics operated by Canabo are staffed by physicians and qualified health care practitioners specifically trained to assess patient suitability for cannabinoid treatment, recommend treatment regimes, and monitor treatment progress.

Forward-Looking Statements

Except for historical information, this press release contains forward-looking statements, which reflect Canabo Medical Inc.’s current expectations regarding future events. These forward-looking statements involve known and unknown risks and uncertainties that could cause Canabo’s actual results to differ materially from those statements. Those risks and uncertainties include, but are not limited to, the Company’s ability to access capital, the successful and timely completion of opening clinics, regulatory changes, competition, approvals and other business and industry risks.

The forward-looking statements in this press release are also based on a number of assumptions which may prove to be incorrect. Forward-looking statements contained in this press release represent views only as of the date of this release and are presented for the purpose of assisting potential investors in understanding Canabo’s business and may not be appropriate for other purposes. Canabo does not undertake to update forward-looking statements, whether written or oral, that may be made from time to time by or on its behalf, except as required under applicable securities legislation. Investors are cautioned not to rely on these forward-looking statements and are encouraged to consult with a professional investment advisor.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

0 534
marijuana-stocks-cannabis-weed1

Although many people associate the legal cannabis industry with the growing and selling of marijuana, the industry has evolved into much more than that.

Canada has proven itself to be a profitable new frontier for cannabis investors and we think this is just the first inning of a multi-decade growth cycle. While licensed producers have been at the forefront of this movements, new opportunities have emerged within the Canadian cannabis market and we want to highlight two undervalued opportunities

Reliq Management Converts Debenture at a Premium

One of the most important metrics to look at when it comes to cannabis stocks is insider activity. When insiders are buying stock in their own company, it is a positive and helps reaffirm the long-term value proposition of the company. When insiders are selling, it is typically not a good sign.

Reliq Health Technologies (RHT.V) (RQHTF) is a stock we have been favorable on as the company continues to execute on its previously announced initiatives and work towards creating value for its shareholders.

Earlier this week, Reliq CFO Amandeep Thindal converted his $100,000 debenture into equity at $0.13 cents, a premium to yesterday’s closing price. This is a bullish sign for Reliq and we see value in the shares at current levels. The company significantly strengthened its balance sheet and closed an oversubscribed financing round. The company raise $763,000 after initially planning to raise only $500,000.

Over the last quarter, Reliq has significantly advanced and improved its fundamental story as it created new strategic partnerships, commenced new pilot programs, and started to generate recurring revenue.

Reliq is focused on securing new contracts with home care agencies, assisted living facilities and hospitals in North America. The company expects to achieve profitability by the end of 2017. We are favorable on Reliq due to its ability to disrupt a multi-billion-dollar market, its management team, its pilot programs, and its valuation.

Lexaria Strengthens its Patent Portfolio

Today, Lexaria Bioscience Corp. (LXRP) (LXX.CN) filed a new provisional patent application with the US Patent and Trademark Office. The new patent application expands Lexaria’s lipophilic food and beverage composition claims to include microwave (dielectric energy) processing as well as heating/dehydration in a vacuum environment.

The patent application covers processing of cannabinoids, vitamins, NSAIDs and nicotine. Lexaria believes that its patent portfolio is the broadest of any comparable company in North America. Lexaria has 19 patent applications filed and pending in more than 40 countries worldwide.

This development is significant and follows the company’s successful application in October 2016 when Lexaria was issued United States Patent pertaining to its method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products.

Lexaria’s technology makes cannabis edibles taste better and makes the active ingredients enter the bloodstream more quickly and much more effectively. The patent protects Lexaria’s intellectual property related to the primary focus of its business, the infusion of cannabinoid compounds in edible products.

Authored By: Jason Spatafora

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements